Qiagen to Transfer Transplant Dx Rights to Olerup

Qiagen will transfer distribution rights for the Olerup line of molecular transplantation testing products to LinkMed subsidiary Olerup International, but also said that it will increase its focus on higher-growth applications in transplantation testing, such as sequencing-based typing.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories